Page 93 - Read Online

Page 14 of 15 Slattery et al. Neuroimmunol Neuroinflammation 2018;5:11 I http://dx.doi.org/10.20517/2347-8659.2018.05

30. Caballero FJ, Soler-Torronteras R, Lara-Chica M, Garcia V, Fiebich BL, Munoz E, Calzado MA. AM404 inhibits NFAT and NF-kappa
B signaling pathways and impairs migration and invasiveness of neuroblastoma cells. Eur J Pharmacol 2015;746:221-32.
31. Umathe SN, Manna SSS, Utturwar KS, Jain NS. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1191-9.
32. Zaitone SA, El-Wakeil AF, Abou-El-Ela SH. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of
acetaminophen in the mouse elevated plus-maze test. Behav Pharmacol 2012;23:417-25.
33. Schultz S, DeSilva M, Gu TT, Qiang M, Whang K. Effects of the analgesic acetaminophen (paracetamol) and its para-aminophenol
metabolite on viability of mouse-cultured cortical neurons. Bas Clin Pharmacol Toxicol 2012;110:141-4.
34. Farizatto KLG, McEwan SA, Naidoo V, Nikas SP, Shukla VG, Almeida MF, Byrd A, Romine H, Karanian DA, Makriyannis A, Bahr
BA. Inhibitor of endocannabinoid deactivation protects against in vitro and in vivo neurotoxic effects of paraoxon. J Mol Neurosci
2017;63:115-22.
35. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal
macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-12.
36. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary
microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009;26:83-94.
37. Ivanov VM. The 125th Anniversary of the Griess Reagent. J Anal Chem 2004;59:1002-5.
38. Kelm M. Nitric oxide metabolism and breakdown. Biochi Biophys Acta 1999;1411:273-89.
39. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of
cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;115:61-9.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol
Methods 1983;65:55-63.
41. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines
following exposure to cadmium chloride. Toxicol Lett 2006;160:171-7.
42. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods
2000;96:147-52.
43. Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease.
J Neuroinflammation 2012;9:115.
44. Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010;23:153-65.
45. Hwang SY, Jung JS, Lim SJ, Kim JY, Kim TH, Cho KH, Han IO. LY294002 inhibits interferon-gamma-stimulated inducible nitric oxide
synthase expression in BV2 microglial cells. Biochem Biophys Res Commun 2004;318:691-7.
46. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK. HMGB1, a novel cytokine-like mediator
linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006;26:6413-21.
47. Mallet C, Barriere DA, Ermund A, Jonsson BAG, Eschalier A, Zygmunt PM, Hogestatt ED. TRPV1 in brain is involved in
acetaminophen-induced antinociception. PLoS One 2010;5:e12748.
48. Tham CS, Whitaker J, Luo L, Webb M. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of
inflammatory mediators. FEBS Lett 2007;581:2899-904.
49. Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW. Actions of the FAAH inhibitor URB597 in neuropathic
and inflammatory chronic pain models. Br J Pharmacol 2006;147:281-8.
50. Otrubova K, Ezzili C, Boger DL. The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH). Bioorg Med
Chem Lett 2011;21:4674-85.
51. Giuffrida A, Beltramo M, Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp
Ther 2001;298:7-14.
52. Rhoades KL, Golub SH, Economou JS. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell,
and B cell lines. J Biol Chem 1992;267:22102-7.
53. Roche M, Kelly JP, O’Driscoll M, Finn DP. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced
alterations in circulating cytokine levels in rats. Immunology 2008;125:263-71.
54. Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative
diseases. Trends Pharmacol Sci 2007;28:180-7.
55. Klegeris A, Bissonnette CJ, McGeer PL. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the
cannabinoid-type CB2 receptor. Br J Pharmacol 2003;139:775-86.
56. Racz I, Nadal X, Alferink J, Banos JE, Rehnelt J, Martin M, Pintado B, Gutierrez-Adan A, Sanguino E, Bellora N, Manzanares J,
Zimmer A, Maldonado R. Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J
Neurosci 2008;28:12136-45.
57. Franklin A, Stella N. Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-
cannabidiol-sensitive receptors. Eur J Pharmacol 2003;474:195-8.
58. Fraga D, Raborn ES, Ferreira GA, Cabral GA. Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat. J
Neuroimmune Pharmacol 2011;6:566-77.
59. Kopalli SR, Koppula S. Carum carvi linn (umbelliferae) attenuates lipopolysaccharide-induced neuroinflammatory responses via
regulation of NF-kappa B signaling in BV-2 microglia. Trop J Pharm Res 2015;14:1041-7.
60. Du ZY, Li XY. Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int J
Immunopharmacol 1999;21:219-25.